Form D · Other Technology
Medaxion, Inc. / DE
Nashville, TN · CIK 0001985259
Offering snapshot reported Jul 13, 2023 · SEC filing
- Reported sold
- $20M Offering amount: $20M
- Investors reported
- 81 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 28, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2023 | Initial | $20,000,000 | No comparison | 81 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $1.75M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-486771
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| PIPER SANDLER & CO. | 665 |
Source: Form D, filed Jul 13, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alyssa M. Anglin | Director |
| Susan A. Brownie | Executive |
| Lucius E. Burch Iv | Director |
| Richard R. D'antoni | Director |
| Phillip N. Dudley | Director |
| James Graves | Director |
| Jeffrey Mc Laren | Director, Executive |
| Jonathan J. Wegner | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
35 Music Square E Suite 300
Nashville, TN, 37203
Nashville, TN, 37203